Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Heart Journal

• Publication date

  2017-01-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1536/ihj.16-188PMID 28123161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).

  2015cited by this paper
• Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening

  2015cited by this paper
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

  2015cited by this paper
• Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.

  2015cited by this paper
• Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.

  2015cited by this paper
• Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.

  2015cited by this paper
• Canadian Cardiovascular Society position statement on familial hypercholesterolemia.

  2014cited by this paper
• Recommendations for the Management of Patients with Familial Hypercholesterolemia

  2014cited by this paper
• HOMOZYGOUS AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN THE NETHERLANDS: PREVALENCE, GENOTYPE-PHENOTYPE RELATIONSHIP AND CLINICAL OUTCOME

  2014cited by this paper
• Familial hypercholesterolaemia

  2014cited by this paper
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.

  2014cited by this paper
• The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study.

  2014cited by this paper
• [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 1) Overview of guidelines: concepts of making clinical practice guidelines and discussion on their social impacts. (2) Evidence-based practic

  2013cited by this paper
• 1）ガイドライン概観～ガイドライン作成のコンセプトと社会的意義をどう考えるか～（2）科学的根拠に基づく糖尿病診療ガイドライン

  2013cited by this paper
• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease

  2013cited by this paper
• The third universal definition of myocardial infarction

  2013cited by this paper
• Defining patients at extremely high risk for coronary artery disease in heterozygous familial hypercholesterolemia.

  2012cited by this paper
• Guidelines for the management of familial hypercholesterolemia.

  2012cited by this paper
• Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.

  2012cited by this paper
• Third universal definition of myocardial infarction.

  2012cited by this paper
• Third universal definition of myocardial infarction.

  2012cited by this paper
• Molecular characterization of familial hypercholesterolemia in Spain.

  2012cited by this paper
• Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

  2011cited by this paper
• Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

  2011cited by this paper
• Familial hypercholesterolemia

  2011cited by this paper
• Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia.

  2010cited by this paper
• Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.

  2009cited by this paper
• Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

  2008cited by this paper
• Familial hypercholesterolaemia: summary of NICE guidance

  2008cited by this paper
• Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.

  2008cited by this paper
• Guidelines - Familial hypercholesterolaemia: summary of NICE guidance

  2008cited by this paper
• Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan.

  2008cited by this paper
• Guidelines for the diagnosis and management of familial hypercholesterolaemia.

  2007cited by this paper
• Familial hypercholesterolemia: a missed opportunity in preventive medicine

  2007cited by this paper
• Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.

  2005cited by this paper
• Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Receptor Gene Mutation

  2005cited by this paper
• Familial hypercholesterolemia

  2002cited by this paper
• Familial hypercholesterolaemia is underdiagnosed after AMI

  2001cited by this paper
• Secondary prevention with lipid lowering therapy in familial hypercholesterolemia: a correlation between new evolution of stenotic lesion and achieved cholesterol levels after revascularization procedures.

  1999cited by this paper
• Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia.

  1996cited by this paper
• Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease

  1992cited by this paper
• Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

  1991cited by this paper
• Achilles tendon thickness in hypercholesterolaemia.

  1981cited by this paper
• Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness.

  1977cited by this paper
• Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.

  1975cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper

• Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study　― Rationale and Study Design ―

  2026cites this paper
• Familial Hypercholesterolaemia in the Asia-Pacific Region

  2025cites this paper
• Association Between Achilles Tendon Thickness and Long-Term Cardio-vascular Outcomes in Elderly Patients Post-PCI

  2025influential citation
• Contrasting Evidences Between High Cholesterol Levels and The Risk of Cardiovascular Disease: A Review

  2024cites this paper
• JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease.

  2024cites this paper
• Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis

  2023cites this paper
• Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up.

  2023cites this paper
• Can Achilles Tendon Assessment of Adult Familial Hypercholesterolemia be Reflected as a Risk Factor for Arteriosclerosis?

  2022cites this paper
• Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia

  2022cites this paper
• Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention

  2022cites this paper
• Finding Importance for Universal Screening of Familial Hypercholesterolemia

  2021cites this paper
• Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region

  2021cites this paper
• Possible Neoangiogenesis in Achilles Tendon Xanthoma with Familial Hypercholesterolemia: A Novel Approach to Achilles Tendon Xanthoma

  2021cites this paper
• Measurement of Achilles Tendon Thickness is a Key for International Harmonization in Clinical Diagnosis of Familial Hypercholesterolemia

  2021cites this paper
• Heterozygous familial hypercholesterolemia: prevalence and control rates

  2021cites this paper
• Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study

  2021cites this paper
• Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

  2021cites this paper
• Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.

  2021cites this paper
• Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J

  2021cites this paper
• Prevalence and Prognosis of Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome in Mie Prefecture, Japan　- Report From Mie ACS Registry.

  2020cites this paper
• Pragmatic Analysis of Dyslipidemia Involvement in Coronary Artery Disease: A Narrative Review

  2020cites this paper
• Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention.

  2020cites this paper
• Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease

  2020cites this paper
• Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register.

  2020cites this paper
• The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study

  2020cites this paper
• Impact of high-dose statin on cardiovascular outcomes in real-world patients with ST-elevation acute myocardial infarction

  2020cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• TACG_A_202942 71..78

  2019cites this paper
• Application of the Japanese Guidelines for the Diagnosis of Familial Hypercholesterolemia in General Practice:

  2019cites this paper
• Estimating the Prevalence of Familial Hypercholesterolemia in Acute Coronary Syndrome: A Systematic Review and Meta-analysis.

  2019cites this paper
• Outcome and Pathological Characteristics of Primary Malignant Cardiac Tumors.

  2019cites this paper
• High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease

  2019cites this paper
• Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention

  2019cites this paper
• β-glucans and cholesterol (Review)

  2018cites this paper
• Major cardiovascular consequences of familial hypercholesterolemia in Poland from the economic perspective

  2018cites this paper
• 4. Management of Disorders of Lipoprotein Metabolism-Update-

  2018cites this paper
• Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.

  2018cites this paper
• Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management

  2018cites this paper
• Acute Coronary Syndrome With or Without Heterozygous Familial Hypercholesterolemia.

  2017cites this paper
• New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials

  2017cites this paper